Lipoxin A<sub>4</sub>and aspirin-triggered 15-epi-lipoxin A<sub>4</sub>inhibit peroxynitrite formation, NF-κB and AP-1 activation, and IL-8 gene expression in human leukocytes

  • Levente József
    Research Center, Maisonneuve-Rosemont Hospital and Department of Medicine, University of Montréal, Montréal, QC, Canada H1T 2M4; Department of Chemistry, University of Southern California, Los Angeles, CA 90089; and Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115
  • Christine Zouki
    Research Center, Maisonneuve-Rosemont Hospital and Department of Medicine, University of Montréal, Montréal, QC, Canada H1T 2M4; Department of Chemistry, University of Southern California, Los Angeles, CA 90089; and Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115
  • Nicos A. Petasis
    Research Center, Maisonneuve-Rosemont Hospital and Department of Medicine, University of Montréal, Montréal, QC, Canada H1T 2M4; Department of Chemistry, University of Southern California, Los Angeles, CA 90089; and Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115
  • Charles N. Serhan
    Research Center, Maisonneuve-Rosemont Hospital and Department of Medicine, University of Montréal, Montréal, QC, Canada H1T 2M4; Department of Chemistry, University of Southern California, Los Angeles, CA 90089; and Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115
  • János G. Filep
    Research Center, Maisonneuve-Rosemont Hospital and Department of Medicine, University of Montréal, Montréal, QC, Canada H1T 2M4; Department of Chemistry, University of Southern California, Los Angeles, CA 90089; and Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115

書誌事項

公開日
2002-09-16
DOI
  • 10.1073/pnas.202296999
公開者
Proceedings of the National Academy of Sciences

この論文をさがす

説明

<jats:p>Lipoxin A<jats:sub>4</jats:sub>(LXA<jats:sub>4</jats:sub>) and aspirin-triggered 15-epi-LXA<jats:sub>4</jats:sub>(ATL) are emerging as endogenous braking signals for neutrophil-mediated tissue injury. Recent studies indicate that peroxynitrite (ONOO<jats:sup>−</jats:sup>) may function as an intracellular signal for the production of IL-8, a potent proinflammatory cytokine in human leukocytes. In this study, we evaluated the impact of the metabolically stable analogues of LXA<jats:sub>4</jats:sub>/ATL on lipopolysaccharide (LPS)-induced ONOO<jats:sup>−</jats:sup>formation and ONOO<jats:sup>−</jats:sup>-mediated IL-8 gene expression in human leukocytes. At nanomolar concentrations, LXA<jats:sub>4</jats:sub>analogues markedly reduced LPS-stimulated superoxide formation, evoked increases in intracellular diamino-fluorescein fluorescence (an indicator of NO formation), and consequently reduced ONOO<jats:sup>−</jats:sup>formation in isolated neutrophils, as well as in neutrophils, monocytes, and lymphocytes, in whole blood. LXA<jats:sub>4</jats:sub>/ATL analogues attenuated nuclear accumulation of activator protein-1 and nuclear factor-κB in both polymorphonuclear and mononuclear leukocytes and inhibited IL-8 mRNA expression and IL-8 release by 50–65% in response to LPS. The LXA<jats:sub>4</jats:sub>inhibitory responses were concentration dependent and were not shared by 15-deoxy-LXA<jats:sub>4</jats:sub>. None of the LXA<jats:sub>4</jats:sub>analogues studied affected neutrophil survival, nor reversed the apoptosis delaying action of LPS in neutrophils. In addition, LXA<jats:sub>4</jats:sub>analogues had no significant effect on exogenous ONOO<jats:sup>−</jats:sup>-induced IL-8 gene and protein expression. These findings suggest that by attenuating ONOO<jats:sup>−</jats:sup>formation, LXA<jats:sub>4</jats:sub>and ATL can oppose ONOO<jats:sup>−</jats:sup>signaling in leukocytes and provide a rationale for using stable synthetic analogues as antiinflammatory compounds<jats:italic>in vivo</jats:italic>.</jats:p>

収録刊行物

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ